The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells.

by Joana Sales-Dias, Gabriela Silva, Márcia Lamy, Andreia Ferreira, Ana Barbas
Published 2019-01-01

Challenges in Antibody Development against Tn and Sialyl-Tn Antigens

by Liliana R. Loureiro, Mylène A. Carrascal, Ana Barbas, José S. Ramalho, Carlos Novo, Philippe Delannoy, Paula A. Videira
Published 2015-08-01

Correction: Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product.

by Filipa P Reis, Ana Barbas, A A Klauer-King, Borislava Tsanova, Daneen Schaeffer, Eduardo López-Viñas, Paulino Gómez-Puertas, Ambro van Hoof, Cecília M Arraiano
Published 2015-01-01

Modulating the RNA processing and decay by the exosome: altering Rrp44/Dis3 activity and end-product.

by Filipa P Reis, Ana Barbas, A A Klauer-King, Borislava Tsanova, Daneen Schaeffer, Eduardo López-Viñas, Paulino Gómez-Puertas, Ambro van Hoof, Cecília M Arraiano
Published 2013-01-01

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer

by Gabriela Silva, Joana Sales-Dias, Diogo Casal, Sara Alves, Giacomo Domenici, Clara Barreto, Carolina Matos, Ana R. Lemos, Ana T. Matias, Khrystyna Kucheryava, Andreia Ferreira, Maria Raquel Moita, Sofia Braga, Catarina Brito, M. Guadalupe Cabral, Cristina Casalou, Duarte C. Barral, Pedro M. F. Sousa, Paula A. Videira, Tiago M. Bandeiras, Ana Barbas
Published 2021-08-01